Pharmaceutical toxicology experts are integral to ensuring the safety and efficacy of new drugs throughout the development process. They assess the potential risks of pharmaceutical compounds by conducting preclinical studies, analyzing data, and interpreting toxicological findings to inform drug development decisions. Their expertise is crucial in identifying potential adverse effects and determining safe dosage levels, thereby protecting public health and ensuring regulatory compliance.
Pharmaceutical toxicology experts collaborate closely with research and development teams, regulatory agencies, and other stakeholders to provide toxicological insights during the drug design process. They play a key role in preparing regulatory submissions, such as pre-IND and IND packages, and may participate in meetings with agencies like the FDA and EMA to address safety concerns and support clinical development. Their work not only contributes to the development of safe and effective medications but also supports the pharmaceutical industry’s efforts to meet evolving regulatory requirements and market demands. Their contributions are pivotal in shaping the future of personalized medicine and targeted therapies. Additionally, pharmaceutical toxicology experts often engage in post-market surveillance to monitor the long-term safety of drugs, identifying rare or delayed adverse effects that may not have been apparent during clinical trials. They also contribute to the development of safety standards and guidelines that influence public health policies and practices.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada